Skip to main content
profile image
Selected Works of Philip Mease, MD
Presentation
Secukinumab Provides Early and Long Lasting Pain Relief in Biologic-naïve Patients with Psoriatic Arthritis: 2-Year Results from the Future-2 Study. 19th Asia Pacific League of Associations for Rheumatology Congress (APLAR 2017), Dubai, U.A.E., Oct 2017.
19th Asia Pacific League of Associations for Rheumatology Congress (APLAR 2017) (2017)
  • Philip Mease, Providence St. Joseph Health
Link
Disciplines
Publication Date
October, 2017
Citation Information
Philip Mease. "Secukinumab Provides Early and Long Lasting Pain Relief in Biologic-naïve Patients with Psoriatic Arthritis: 2-Year Results from the Future-2 Study. 19th Asia Pacific League of Associations for Rheumatology Congress (APLAR 2017), Dubai, U.A.E., Oct 2017." 19th Asia Pacific League of Associations for Rheumatology Congress (APLAR 2017) (2017)
Available at: http://works.bepress.com/philip-mease/183/